Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-21-006312

President sold 30,000 shares at an average $57.39 ($1,721,580)

  • President acquired 30,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

RUBINSTEIN JULIE · President

Table I: Non-derivative

8 lines
Date Transaction Shares Price Value Owned after D/I
2021-01-27 Exercise or conversion : show line 1 in the form +15,000 $6.32 $94,800 15,000 D
2021-01-27 Sale : show line 2 in the form −6,387 $58.19 $371,660 8,613 D
2021-01-27 Sale : show line 3 in the form −6,913 $59.37 $410,425 1,700 D
2021-01-27 Sale : show line 4 in the form −1,700 $59.99 $101,983 0 D
2021-01-28 Exercise or conversion : show line 5 in the form +15,000 $6.32 $94,800 15,000 D
2021-01-28 Sale : show line 6 in the form −3,433 $54.96 $188,678 10,567 D
2021-01-28 Sale : show line 7 in the form −9,420 $55.96 $527,143 2,147 D
2021-01-28 Sale : show line 8 in the form −2,147 $56.68 $121,692 0 D
Open-market sales · 30,000 sh · avg $57.39 · $1,721,580

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2021-01-27 Exercise or conversion : show line 9 in the form Stock Option (Right to Buy) −15,000 125,000 D
2021-01-28 Exercise or conversion : show line 10 in the form Stock Option (Right to Buy) −15,000 110,000 D
Loading xslF345X03/doc4.xml…